12.7 C
Madrid
Sunday, September 19, 2021

AYUSH 64 – Ayush Medicine For Treatment Of COVID-19

AYUSH 64, a polyherbal formulation developed by the Central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of AYUSH has been scientifically found to be useful in the treatment of asymptomatic & mild cases as standalone

Must read

Pradeep Chamaria
Pradeep Chamaria
I am a photojournalist. Love to travel to unknown and unexplored vistas. Since 1992, I make places desirable for other travelers through experiential Travel Writing.

INDIA. New Delhi: AYUSH 64, a polyherbal formulation developed by the Central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of Ayush has been scientifically found to be useful in the treatment of asymptomatic & mild cases as standalone. It has been also found useful for the management of mild and moderate COVID-19 infection as an adjunct to standard care through robust clinical trials conducted in the country by the Ministry of Ayush in collaboration with CSIR and by CCRAS and National Institutes under the Ministry of Ayush. AYUSH 64 is also recommended in “National Clinical Management Protocol based on Ayurveda and Yoga for management of COVID-19” prepared by the National Task Force in consensus from various expert committees.

Ministry of Ayush has been conducting studies under various research organisations and National Research Institutes. 126 studies have been initiated in 152 centers in India to identify effective medicine for managing patients with symptoms of COVID-19. It includes 42 prophylactic studies, 40 interventional studies, 11 observational studies, 22 pre-clinical/experimental studies, 01 systematic review, 08 survey studies, and 02 monographs preparation. The system-wise research studies include 66 from Ayurveda, 26 from Homoeopathy, 13 from Siddha, 08 from Unani, and 13 from Yoga & Naturopathy. Total 90 studies have been completed and 10 manuscripts have been published.

- Advertisement -

The Ministry of AYUSH has formed an Inter-disciplinary AYUSH R&D Task Force having representation from the Indian Council of Medical Research (ICMR), Department of Biotechnology (DBT), Council of Scientific and Industrial Research (CSIR), All India Institute of Medical Sciences (AIIMS) and AYUSH Institutions. The Inter-disciplinary AYUSH R&D Task Force has formulated and designed clinical research protocols for prophylactic studies and add-on interventions in COVID-19 positive cases for studying four different interventions viz. Ashwagandha, Yashtimadhu, Guduchi + Pippali and a polyherbal formulation (AYUSH-64).

Further, the Ministry of AYUSH had invited research proposals under the Modified Extra Mural Research Scheme for SARS CoV-2 infection and COVID-19 disease from 21 April 2020 to 10th May 2020. 21 such research projects on the Ayurveda medicine system have been funded under the scheme. Out of which 8 are of Private Institutions and 13 of Government Institutions.

- Advertisement -

Read Also: Popularity Of AYUSH System Of Medicine

Support our mission of Independent Journalism on Patreon!
- Advertisement -

More articles

- Advertisement -

Latest article

Support our mission of Independent Journalism on Patreon!